-
Using CRISPR to modify certain immune cells could make cancer-fighting immunotherapy more potent for a broader set of patients. After undergoing a new form of experimental therapy, Parkville resident Katie Pope Kopp is now in remission.
-
Donavon Decker became, in more ways than one, an ambassador of limb girdle muscular dystrophy type 2D, a rare degenerative disorder. But decades after he participated in patient trials and fundraised for research, drug companies are still nowhere close to a cure.